| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/05/2002 | EP1210948A1 Remedies for nervous diseases |
| 06/05/2002 | EP1210940A2 Antifatigue composition |
| 06/05/2002 | EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210454A1 Antisense modulation of shp-1 expression |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210430A2 Muc-1 derived peptides |
| 06/05/2002 | EP1210429A2 Apoptosis proteins |
| 06/05/2002 | EP1210426A2 Polymorphisms in a klotho gene |
| 06/05/2002 | EP1210425A2 Baff receptor (bcma), an immunoregulatory agent |
| 06/05/2002 | EP1210422A2 Human abc2 transporter and uses thereof |
| 06/05/2002 | EP1210421A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210370A1 Human tumor necrosis factor receptor tr16 |
| 06/05/2002 | EP1210357A1 OLIGONUCLEOTIDE N3'$m(7)P5' THIOPHOSPHORAMIDATES: THEIR SYNTHESIS AND USE |
| 06/05/2002 | EP1210349A2 PYRAZOLO 4,3-d]PYRIMIDINES |
| 06/05/2002 | EP1210348A1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 06/05/2002 | EP1210343A2 Benzoic acid derivatives and their use as ppar receptor agonists |
| 06/05/2002 | EP1210339A1 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 06/05/2002 | EP1210338A2 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system |
| 06/05/2002 | EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 06/05/2002 | EP1210329A2 Aminoalkoxy carbazoles and their use as 5-ht ligands |
| 06/05/2002 | EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands |
| 06/05/2002 | EP1210326A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 06/05/2002 | EP1210320A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210123A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 06/05/2002 | EP1210121A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 06/05/2002 | EP1210119A1 Pharmaceutical compositions for oral and topical administration |
| 06/05/2002 | EP1210117A2 Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 06/05/2002 | EP1210115A1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 06/05/2002 | EP1210108A2 Use of leptin in inhibition of endothelial cell proliferation |
| 06/05/2002 | EP1210102A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/05/2002 | EP1210100A1 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 06/05/2002 | EP1210091A1 Heartburn treatment |
| 06/05/2002 | EP1210087A2 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
| 06/05/2002 | EP1210084A1 Pyridomorphinans, thienomoprhinans and use thereof |
| 06/05/2002 | EP1210079A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 06/05/2002 | EP1210078A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 06/05/2002 | EP1210076A2 Drug therapy of the restless leg syndrome |
| 06/05/2002 | EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 06/05/2002 | EP1210046A1 Enhanced wound coverage to enhance wound healing |
| 06/05/2002 | EP1109573B1 PHARMACEUTICAL COMPOSITIONS COMPRISING FACTOR XIIIa FOR NERVE HEALING |
| 06/05/2002 | EP1061909B1 Keto acid salts and amine derivatives, and their use for preparing medicines |
| 06/05/2002 | EP1037658B1 Ifnar/ifn complex |
| 06/05/2002 | EP1023273B1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5ht1a receptors |
| 06/05/2002 | EP0975592B1 Benzyloxy prodigiosine compounds |
| 06/05/2002 | EP0970090B1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
| 06/05/2002 | EP0951474B1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them |
| 06/05/2002 | EP0944628B1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| 06/05/2002 | EP0923551B1 4-aminoethoxy indolone derivatives |
| 06/05/2002 | EP0888337B1 Piperidone tachykinin antagonists |
| 06/05/2002 | EP0876336B1 Azahexane derivatives as substrate isosters of retroviral asparate proteases |
| 06/05/2002 | EP0871443B1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 06/05/2002 | EP0858338B1 Use of levo-enantiomers of medetomidine derivatives |
| 06/05/2002 | EP0851855B1 Acylated derivatives of melatonin and its analogues, useful as medicaments |
| 06/05/2002 | EP0819007B1 Urinary bladder submucosa derived tissue graft |
| 06/05/2002 | EP0804182B1 Use of gabapentin in the treatment of anxiety and panic |
| 06/05/2002 | EP0788361B1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 06/05/2002 | EP0758241B1 Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration |
| 06/05/2002 | EP0736095B1 Human circulating cytokine cc-1 |
| 06/05/2002 | EP0735900B1 Paramagnetic diagnostic formulations and their method of use |
| 06/05/2002 | EP0711282B1 Compounds as pde iv and tnf inhibitors |
| 06/05/2002 | EP0632723B1 Use of transglutaminase inhibitor for the treatment of scar tissue |
| 06/05/2002 | EP0629199B1 Indole derivatives as 5-ht1 agonists |
| 06/05/2002 | EP0612211B1 Alteration of rate and character of hair growth |
| 06/05/2002 | CN1352694A Novel system for regulating transgene expression |
| 06/05/2002 | CN1352691A Human complement C3-degrading polypeptide from i(streptococcus pneumoniae) |
| 06/05/2002 | CN1352687A A variant of c6 beta-chemokine leukotactin-1 (shLKn-1) with enhanced biological activity |
| 06/05/2002 | CN1352684A Vascular endothelial cell growth factor variants and use thereof |
| 06/05/2002 | CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV |
| 06/05/2002 | CN1352642A Farnesyl protein transferase inhibitors |
| 06/05/2002 | CN1352636A Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 06/05/2002 | CN1352635A Quinoline derivatives as inhibitors of MEK enzymes |
| 06/05/2002 | CN1352634A Process for preparing amlodipine benzenesulphonate |
| 06/05/2002 | CN1352632A N-substituted-N'-substituted urea derivative and use thereof as TNF-Alpha production inhibitor |
| 06/05/2002 | CN1352568A Water soluble compositions for bioactive lipophilic compounds |
| 06/05/2002 | CN1352563A Use of phyllanthus for targeted stimulation of the immune system |
| 06/05/2002 | CN1352561A Method for enhancing the efficacy of anti-tumor agents |
| 06/05/2002 | CN1352559A Endoparasiticidal combination |
| 06/05/2002 | CN1352557A Compositions for improivng fertility |
| 06/05/2002 | CN1352554A IL-8 receptor antagaonists |
| 06/05/2002 | CN1085981C Nicotinic acid ester compounds and its salts, their preparation and medicine composition containing them |
| 06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
| 06/05/2002 | CN1085945C 7-(2-imidazolinylamino) quinoline compounds as alpha -2 adrenocepter agonists |
| 06/05/2002 | CA2364211A1 Combination treatment for depression, anxiety and psychosis |
| 06/04/2002 | US6399824 For therapy and prophylaxis of arrhythmias, cardiac infraction, ischemic conditions, angina pectoris, shock, for preserving and storing a transplant for surgical measure |
| 06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
| 06/04/2002 | US6399778 Crystalline solvate |
| 06/04/2002 | US6399773 Autoimmune disease; transplanting organs |
| 06/04/2002 | US6399648 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/04/2002 | US6399647 Amide derivatives for antiangiogenic and/or antitumorigenic use |
| 06/04/2002 | US6399643 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations formed therefrom |
| 06/04/2002 | US6399642 Tris benzimidazoles; fungicides, anticarcinogenic agents, enzyme inhibitor |
| 06/04/2002 | US6399641 For therapy and prophylaxis of psychosis, schizophrenia, alzheimer's disease, cognitive disorders and restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries etc. |
| 06/04/2002 | US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain |
| 06/04/2002 | US6399634 Benzothiophene compounds, compositions, and methods |
| 06/04/2002 | US6399633 Flavopiridol; low dosage; vascular lesions after ballon or stent |
| 06/04/2002 | US6399632 Administering terfenadine acid metabolite; avoiding cardiac arrhythmias; fexofenadine; carboxyterfenadine |
| 06/04/2002 | US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives |